References / Literature - DRG EIA-2395 Instrucciones De Uso

12

REFERENCES / LITERATURE

1. Londraville RL, et al. Comparative endocrinology of leptin: assessing function in a phylogenetic context.
Gen Comp Endocrinol (2014) 203:146–57.
2. Bjorbaek C, Kahn BB. Leptin signaling in the central nervous system and the periphery.
Recent Prog Horm Res (2004) 59:305–32.
3. Arora S. Leptin and its metabolic interactions – an update.
Diabetes Obes Metab (2008) 10(11): 973–93.
4. Elias CF et al. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area.
Neuron (1999) 23(4):775–86.
5. Elmquist JK. Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin.
Physiol Behav (2001) 74(4):703–8.
6. Brennan AM, Mantzoros CS (2006). Drug Insight: the role of leptin in human physiology and pathophysiology--
emerging clinical applications".
Nat Clin Pract Endocrinol Metab. 2 (6): 318–27.
7. Considine RV et al.(1996). "Serum immunoreactive-leptin concentrations in normal-weight and obese humans".
N. Engl. J. Med. 334 (5): 292–5.
8. Pan H, Guo J, Su Z (May 2014). "Advances in understanding the interrelations between leptin resistance and
obesity".
Physiology & Behavior. 130: 157–169.
9. Ahima RS, Qi Y, Singhal NS, Jackson MB, Scherer PE. Brain adipocytokine action and metabolic regulation.
Diabetes (2006) 55(Suppl 2):145–54.
10. Ahima RS, Flier JS. Adipose tissue as an endocrine organ.
Trends Endocrinol Metab (2000) 11(8): 327–32.
11. Weigle DS et al. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse.
J Clin Invest (1995) 96(4):2065
12. Farooqi IS et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic
dysfunction of human congenital leptin deficiency.
J Clin Invest (2002) 110(8):1093–103.
Version 10.0 2017/05 - vk
Leptin Sandwich ELISA EIA-2395
-
33 -